A cloud-based platform with clinical decision support tools designed to optimize the management of liver diseases and assist in guiding treatment decisions. It integrates with FibroScan data and other clinical information for comprehensive liver health assessment.
Manufactured by
Echosens China
China
Echosens, founded in 2001 and headquartered in France, is a global leader in non-invasive liver health management solutions. The company established its wholly-owned China subsidiary, Shenzhen Huibo Medical Device Co., Ltd., in 2015. Echosens pioneered Vibration-Controlled Transient Elastography (VCTE®) and Controlled Attenuation Parameter (CAP™) technologies in FibroScan® devices for assessing liver fibrosis, portal hypertension, and hepatic steatosis, with 5,600+ peer-reviewed publications and 200+ international guideline endorsements.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hisky Medical
China · 3 relevant products
Beijing sinotech&wellcare technology and development Co.,Ltd
China · 3 relevant products
Wuhan Jiule Technology Co., Ltd
China · 1 relevant product
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →8 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 86 closest product alternatives
Hisky Medical · China
Integrated system for liver disease patient tracking and post-diagnostic management. Facilitates long-term monitoring and clinical decision support for hepatology patients.
Beijing sinotech&wellcare technology and development Co.,Ltd · China
A SaaS-based platform for medical institutions managing chronic diseases including diabetes, coronary heart disease, and stroke across diagnosis, treatment, and rehabilitation. Includes real-time glucose alerts, AI clinical decision support, multi-terminal coordination, and remote consultation capabilities with level 3 data security compliance.
Wuhan Jiule Technology Co., Ltd · China
Comprehensive platform for long-term chronic disease assessment and intervention. Enables patient evaluation, therapeutic planning, and remote monitoring for chronic condition management.
83 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products